Economic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China.

Tan, Chongqing; Peng, Liubao; Zeng, Xiaohui; Li, Jianhe; Wan, Xiaomin; Chen, Gannong; Yi, Lidan; Luo, Xia; Zhao, Ziying

Tan, Chongqing; Peng, Liubao; Zeng, Xiaohui; Li, Jianhe; Wan, Xiaomin; Chen, Gannong; Yi, Lidan; Luo, Xia; Zhao, Ziying.

Affiliation

Tan C; Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, People's Republic of China ; School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, People's Republic of China.

PLoS One ; 8(12): e83396, 2013.

Article in En | MEDLINE | ID: mdl-24340099

Subject(s)

Chemotherapy, Adjuvant/economics; Stomach Neoplasms/drug therapy; Stomach Neoplasms/economics; Stomach Neoplasms/surgery; Antineoplastic Combined Chemotherapy Protocols/economics; Bayes Theorem; Capecitabine; China; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Deoxycytidine/analogs & derivatives; Deoxycytidine/economics; Disease Progression; Disease-Free Survival; Drug Combinations; Fluorouracil/analogs & derivatives; Fluorouracil/economics; Gastrectomy; Humans; Markov Chains; Middle Aged; Models, Statistical; Oxaloacetates; Oxonic Acid/economics; Probability; Quality-Adjusted Life Years; Tegafur/economics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Chemotherapy, Adjuvant Type of study: Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans / Middle aged Country/Region as subject: Asia Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2013 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google